Family-Based Prevention Program for Childhood Anxiety

Sponsor
Johns Hopkins University (Other)
Overall Status
Completed
CT.gov ID
NCT00078728
Collaborator
National Institute of Mental Health (NIMH) (NIH)
40
1
2
46
0.9

Study Details

Study Description

Brief Summary

This study will evaluate the effectiveness of a short-term family-based program for preventing anxiety disorders in at-risk children.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Family-Based Anxiety Prevention Program
  • Behavioral: Evaluation only
N/A

Detailed Description

Anxiety disorders are serious conditions that can negatively impact a person's overall functioning. This study will enroll mothers with anxiety disorders and their children to determine whether a brief family-based intervention will reduce childhood anxiety better than standard care.

Participants will be randomly assigned to either the family-based prevention program or to evaluation only for 8 weeks. Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety. Self- and parent-reports, diagnostic interviews, a computerized memory task, and a videotaped parent-child interaction task will be used to assess participants. Assessments will be conducted at study start and one week after intervention completion (Week 9). Follow-up visits will be conducted at 6 and 12 months after intervention completion.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Family-Based Prevention for Childhood Anxiety
Study Start Date :
Sep 1, 2003
Actual Primary Completion Date :
Jul 1, 2007
Actual Study Completion Date :
Jul 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: Family-based anxiety prevention program

Participants will complete an 8 session (1 session/week), cognitive behavioral therapy-based, family prevention program to be administered by a trained clinician, after randomization to the study. The prevention program will include 3 booster sessions that take place after the first 8 sessions.

Behavioral: Family-Based Anxiety Prevention Program
Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. The intervention will begin immediately after randomization to the study.

Active Comparator: Evaluation only

Waitlist control group. Participants in this group will receive general information (in the form of a printed packet) about anxiety after randomization to the study. Families in this group will complete all study evaluations and will then be offered the option of participating in the prevention program. Families who accept will begin the prevention sessions and will receive the same CBT-based, family-based prevention program as the other treatment arm.

Behavioral: Evaluation only
Participants will undergo evaluations without active treatment for 8 weeks.

Outcome Measures

Primary Outcome Measures

  1. Number of Children With Child Anxiety Diagnosis [12 month]

    Measured by the Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders 4th edition, child and parent versions.

  2. Child Anxiety Diagnoses [12 months]

    The cumulative number of children who developed an anxiety disorder at each assessment point during the study. Using the intent to treat sample, a total of 6 children in the non-intervention group developed an anxiety disorder by the 12-month assessment. No children in the CAPS group developed an anxiety disorder.

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Mothers with a current, primary anxiety disorder

  • 7-12 year old children without an anxiety disorder

Exclusion Criteria:
  • Mothers that do not have a current, primary anxiety disorder

  • 7-12 year old children with an anxiety disorder

  • 7-12 year old children that are currently receiving treatment for anxiety that could interfere with the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Johns Hopkins University School of Medicine Baltimore Maryland United States 21205

Sponsors and Collaborators

  • Johns Hopkins University
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Golda S. Ginsburg, PhD, Johns Hopkins University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00078728
Other Study ID Numbers:
  • K23MH063427
  • K23MH063427
First Posted:
Mar 8, 2004
Last Update Posted:
Feb 7, 2018
Last Verified:
Jan 1, 2018
Keywords provided by Johns Hopkins University
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title 1 Family-based Prevention Program 2 Evaluation Only
Arm/Group Description Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks.
Period Title: Overall Study
STARTED 20 20
COMPLETED 16 17
NOT COMPLETED 4 3

Baseline Characteristics

Arm/Group Title 1 Family-based Prevention Program 2 Evaluation Only Total
Arm/Group Description Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks. Total of all reporting groups
Overall Participants 20 20 40
Age (Count of Participants)
<=18 years
20
100%
20
100%
40
100%
Between 18 and 65 years
0
0%
0
0%
0
0%
>=65 years
0
0%
0
0%
0
0%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
9.20
(1.91)
8.68
(1.81)
8.94
(1.85)
Sex: Female, Male (Count of Participants)
Female
10
50%
8
40%
18
45%
Male
10
50%
12
60%
22
55%
Region of Enrollment (participants) [Number]
United States
20
100%
20
100%
40
100%

Outcome Measures

1. Primary Outcome
Title Number of Children With Child Anxiety Diagnosis
Description Measured by the Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders 4th edition, child and parent versions.
Time Frame 12 month

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title 1 Family-based Prevention Program 2 Evaluation Only
Arm/Group Description Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. Evaluation only : Participants will undergo evaluations without active intervention for 8 weeks but received an informational packet on anxiety disorders.
Measure Participants 20 20
Number [participants]
20
100%
20
100%
2. Primary Outcome
Title Child Anxiety Diagnoses
Description The cumulative number of children who developed an anxiety disorder at each assessment point during the study. Using the intent to treat sample, a total of 6 children in the non-intervention group developed an anxiety disorder by the 12-month assessment. No children in the CAPS group developed an anxiety disorder.
Time Frame 12 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title 1 Family-based Prevention Program 2 Evaluation Only
Arm/Group Description Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks.
Measure Participants 20 20
Number [participants]
0
0%
6
30%

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title 1 Family-based Prevention Program 2 Evaluation Only
Arm/Group Description Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks.
All Cause Mortality
1 Family-based Prevention Program 2 Evaluation Only
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
1 Family-based Prevention Program 2 Evaluation Only
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%)
Other (Not Including Serious) Adverse Events
1 Family-based Prevention Program 2 Evaluation Only
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%)

Limitations/Caveats

Of the 40 participants in the study, no adverse events occured or were reported.

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Golda Ginsburg, PhD,Professor
Organization The Johns Hopkins University School of Medicine
Phone 410-955-1544
Email gginnsbu@jhmi.edu
Responsible Party:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00078728
Other Study ID Numbers:
  • K23MH063427
  • K23MH063427
First Posted:
Mar 8, 2004
Last Update Posted:
Feb 7, 2018
Last Verified:
Jan 1, 2018